Author: Hannah Clargo-Jones

We are funding two ambitious new pilot studies designed to spark progress in how we diagnose, monitor and treat brain tumours.

Our Junior Fellow, Mr Ola Rominiyi, explains how his role bridges neurosurgery and scientific discovery.

Our researchers are marking a significant step towards a blood test for glioblastoma.

Researchers in Cambridge have identified a potential new treatment approach for children with brain tumours.

Our Biomedical Scientific Advisory Board (SAB) assesses applications for research funding, recommending those that hold the most potential.

We’re proud to be funding Access to Clinical Trials for Brain Tumours (ACT-BT), a UK-wide initiative that will enable consultants to refer patients to a panel of clinical trial experts.

As 2025 draws to a close, we reflect on an exciting year for research into brain tumours.

We hosted an event focused on improving quality of life for adults living with the effects of a low grade brain tumour.

New research suggests that immune cells in low grade gliomas may help them survive, providing insight that could lead to new treatments for children with these tumours.

Researchers have pinpointed a new biomarker that could help doctors more accurately predict the behaviour of meningiomas.